Novo Nordisk will continue offering its top-selling insulin brand, Mixtard, in vial form in India, despite phasing out Penfill cartridges. This decision follows concerns about the discontinuation ...

Insulin Detemir and Levemir and Xultophy — marketed mostly in the format of pre-filled disposable pen and cartridges (Penfill and FlexPen). The company recently informed its marketing partner ...

5,000 crore insulin market including Actrapid, Insulatard, Insulin Detemir, Levemir and Xultophy, which are marketed primarily in the format of pre-filled disposable pen and cartridges (Penfill and ...

The new PenCycle programme covers Novo Nordisk's FlexPen and FlexTouch devices, which are used to dispense insulin and other medications. Users of the devices in the UK will shortly be able to ...

Novo Nordisk's insulin aspart franchise is a DKK 10.6 billion ($1.5 billion) business worldwide, with NovoLog (known as NovoRapid outside the US) making up the bulk (around DKK 9 billion ...

which are marketed primarily in the format of pre-filled disposable pen and cartridges (Penfill and FlexPen). TOI accessed documents that said the company recently informed marketing partner, Abbott ...

This would include human insulin in penfill and flexpen, including Mixtard 30 Penfill and Flexpen, Actrapid Penfill and Flexpen, Insulatard Penfill and Flexpen, and Mixtard 50 Penfill over the next ...

From military equipment to EVs, how China's halting of rare earth exports could hurt US These are sold primarily in the format of pre-filled disposable pen and cartridges (Penfill and FlexPen).